Trop2 deal heats up antibody-drug conjugate space in cancer
Nat Biotechnol
.
2021 Feb;39(2):128-130.
doi: 10.1038/s41587-021-00824-8.
Author
Catherine Shaffer
1
Affiliation
1
, Ann Arbor, MI, USA.
PMID:
33564163
DOI:
10.1038/s41587-021-00824-8
No abstract available
Publication types
News
MeSH terms
Antigens, Surface / metabolism*
Clinical Trials as Topic
Drug Industry
Humans
Immunoconjugates / therapeutic use*
Molecular Targeted Therapy
Neoplasms / drug therapy*
Substances
Antigens, Surface
Immunoconjugates